Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

Author： Karjalainen Pasi   Ylitalo Antti   Niemela Matti   Kervinen Kari   Makikallio Timo   Pietila Mikko   Sia Jussi   Tuomainen Petri   Nyman Kai   Airaksinen K. E. Juhani  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.41, Iss.8, 2009-01, pp. : 599-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparisons of Everolimus and Paclitaxel‐Eluting Stents in Patients with Acute Myocardial Infarction

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 2, 2015-04 ,pp. : 147-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender disparity in the use of drug‐eluting stents during percutaneous coronary intervention for acute myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 221-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended follow‐up following “full‐metal jacket” percutaneous coronary interventions with drug‐eluting stents

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1042-1050

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease

By Zhang Feng   Dong Lili   Qian Juying   Ge Junbo  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite

Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite